Home > Books > Myeloma: Emerging Cancer Therapeutics
Myeloma: Emerging Cancer Therapeutics
View PDF

Myeloma: Emerging Cancer Therapeutics

Publication Year: 2010
Edition: 1st
Authors/Editor: Kumar
Publisher: Springer Publishing Company
ISBN: 978-1-933-86491-4
Doody's Star Rating®:  Score: 73
  • Description
  • Details

This volume reviews the current literature, provides critical evaluations of the data and offers evidence-based recommendations.

It is estimated that over 20,000 new cases are diagnosed each year with over 10,000 people dying from these malignancies. Multiple myelomas are highly treatable but rarely curable. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management.

Management options and outcomes for individuals with multiple myelomas improved dramatically with the introduction of chemotherapy. Even further improvements in prognosis have occurred because of the introduction of newer therapies such as pulse corticosteroids, thalidomide, bortezomib, and autologous and allogeneic stem cell transplantation. With the increased number of therapeutic options to choose from, the clinician is better placed to offer effective therapy but at the same time is challenged to keep abreast of the rapidly changing treatment landscape and the newly emerging data that is shaping the treatment options today and in the future. Multiple Myeloma provides a comprehensive and in-depth review of this group of malignancies.

About the Series:
Emerging Cancer Therapeutics is an invited review publication providing a through analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence, current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging.

  • Platform:
  • Publisher: Springer Publishing Company
  • Product Type: Book
  • Author/Editor: Kumar
  • ISBN: 978-1-933-86491-4
  • Specialty:
  • Language: English
  • Edition: 1st
  • Pages: 200
  • Illustrations: 0
  • Year: 2010
  • Doody's Star Rating®:  Score: 73

Free Instant Access
This Month

Evidence-Based Medicine Reviews (EBMR) A definitive resource for electronic information in the evidence based medicine movement that combines the most trusted resources into a single, fully-searchable database.
Global Health The only specialist bibliographic abstracting and indexing database dedicated to public health and capturing key literature that is not covered by other databases.
Clinical Orthopaedics and Related Research® Original articles highlighting the latest in clinically relevant basic science of musculoskeletal diseases and their treatments.
Annals of Internal Medicine Published by the American College of Physicians, contains original articles, case reports, topical reviews, editorials, book reviews and medical notices for internal medicine.


Doody's Featured Books
Osborn's Brain: Imaging, Pathology, and Anatomy
Covers the must-know aspects of brain imaging together with spectacular pathology examples, relevant anatomy, and up-to-date techniques in neuroradiology.

Neurology Evidence: The Practice-Changing Studies
Synthesizes the vast body of literature available in neurology into one accessible, clinically relevant volume-features papers that have had the most impact on changing clinical practice.